Uso de la daptomicina
La daptomicina, para su uso en el tratamiento de una infección bacteriana en un paciente humano en necesidad del mismo, en el que una dosis para dicho tratamiento es de 10 mg/kg de daptomicina, en el que dicha dosis se administra repetidamente en un intervalo de administración de una vez cada 24 hor...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | Spanish |
Published |
23.02.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | La daptomicina, para su uso en el tratamiento de una infección bacteriana en un paciente humano en necesidad del mismo, en el que una dosis para dicho tratamiento es de 10 mg/kg de daptomicina, en el que dicha dosis se administra repetidamente en un intervalo de administración de una vez cada 24 horas.
The invention provides methods for administering a therapeutically effective amount of daptomycin while minimizing skeletal muscle toxicity. The methods provide daptomycin administration at a dosing interval of 24 hours or greater. This long dosing interval minimizes skeletal muscle toxicity and allows for higher peak concentrations of daptomycin, which is related to daptomycin's efficacy. The invention also provides methods of administering lipopeptide antibiotics other than daptomycin while minimizing skeletal muscle toxicity by administering a therapeutically effective amount of the lipopeptide antibiotic at a dosage interval that does not result in muscle toxicity. The invention also provides methods of administering quinupristin/dalfopristin while minimizing skeletal muscle toxicity by administering a therapeutically effective amount of quinupristin/dalfopristin at a dosage interval that does not result in muscle toxicity. |
---|---|
AbstractList | La daptomicina, para su uso en el tratamiento de una infección bacteriana en un paciente humano en necesidad del mismo, en el que una dosis para dicho tratamiento es de 10 mg/kg de daptomicina, en el que dicha dosis se administra repetidamente en un intervalo de administración de una vez cada 24 horas.
The invention provides methods for administering a therapeutically effective amount of daptomycin while minimizing skeletal muscle toxicity. The methods provide daptomycin administration at a dosing interval of 24 hours or greater. This long dosing interval minimizes skeletal muscle toxicity and allows for higher peak concentrations of daptomycin, which is related to daptomycin's efficacy. The invention also provides methods of administering lipopeptide antibiotics other than daptomycin while minimizing skeletal muscle toxicity by administering a therapeutically effective amount of the lipopeptide antibiotic at a dosage interval that does not result in muscle toxicity. The invention also provides methods of administering quinupristin/dalfopristin while minimizing skeletal muscle toxicity by administering a therapeutically effective amount of quinupristin/dalfopristin at a dosage interval that does not result in muscle toxicity. |
Author | Oleson, Frederick B. Jr Tally, Francis P |
Author_xml | – fullname: Oleson, Frederick B. Jr – fullname: Tally, Francis P |
BookMark | eNrjYmDJy89L5WQQDS3OV0hJVchJVEhJLCjJz81MzsxL5GFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8a7BRmYGxgYWZiEhxsbEqAEAGlgi5A |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | ES2603086TT3 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_ES2603086TT33 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 13:00:44 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | Spanish |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_ES2603086TT33 |
Notes | Application Number: ES20060006697T |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170223&DB=EPODOC&CC=ES&NR=2603086T3 |
ParticipantIDs | epo_espacenet_ES2603086TT3 |
PublicationCentury | 2000 |
PublicationDate | 20170223 |
PublicationDateYYYYMMDD | 2017-02-23 |
PublicationDate_xml | – month: 02 year: 2017 text: 20170223 day: 23 |
PublicationDecade | 2010 |
PublicationYear | 2017 |
RelatedCompanies | Cubist Pharmaceuticals LLC |
RelatedCompanies_xml | – name: Cubist Pharmaceuticals LLC |
Score | 3.0673335 |
Snippet | La daptomicina, para su uso en el tratamiento de una infección bacteriana en un paciente humano en necesidad del mismo, en el que una dosis para dicho... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Uso de la daptomicina |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170223&DB=EPODOC&locale=&CC=ES&NR=2603086T3 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD7MKeqbzonOCxWkb8V1adL2oQjrhSHsgnayt9EmGRRkK7bi3_cktOqLvoUEDsmBk-_L5TsH4H6YecxDnLVGzNclzHLL45JavhzSzBltGKVKnDydscnSeVrRVQeKVguj84R-6uSIGFEc473W-3X5c4kV6b-V1UNeYNfuMUmDyGxOx7aLkETMaBzEi3k0D80wDJBUzZ4DpO0E2XtK9mBfsWiVZj9-HStRSvkbUZITOFigsW19Ch1Z9eAobAuv9eBw2rx3Y7MJveoM-stqZwhpvGWGyMpaiYmLbdaHuyROw4mF9tffa1nHL-1MUkLOoYtnfHkBBuNsmBOXe8zmjkC3-cIV1OW2JE5uU3EJg7_tDP4bvIJj5RetwibX0K3fP-QN4mid32oPfAH7LXU_ |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwED7mFOebzsmcvyrI3orr0qTtQxHWbkxdt6Gd7G20SYSCbMVW_Pe9hE590beQwJEcXL4vP747gJte4jIXcdbsM0-XMEtNl0tqerJHE7v_yihV4uRoysYL-2FJlzXItloYnSf0UydHxIjiGO-l3q_zn0usUP-tLG7TDLs2d6PYD7vV6dhyEJJINxz4w_ksnAXdIPCRVE2ffKTtBNl7THZg11HJeRVzehkoUUr-G1FGh7A3R2Pr8ghqsmhCI9gWXmvCflS9d2OzCr3iGFqLYmMIabwlhkjyUomJs3XSguvRMA7GJtpffa9lNXzeziQm5ATqeMaXbTAYZ72UONxlFrcFus0TjqAOtySxU4uKU-j8bafz3-AVNMZxNFlN7qePZ3CgfKQV2eQc6uX7h7xATC3TS-2NL56KeCw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Uso+de+la+daptomicina&rft.inventor=Oleson%2C+Frederick+B.+Jr&rft.inventor=Tally%2C+Francis+P&rft.date=2017-02-23&rft.externalDBID=T3&rft.externalDocID=ES2603086TT3 |